Rankings / Metabolic Health

Altitude training / intermittent hypoxia (IHT)

Metabolic Health · Oxygen/Pressure

Tier B+

autophagymitochondrial
7.2 / 10
Tier B+
Ev 8 Bn 5 Sf 7

Bottom line

Read Off Label grades Altitude training / intermittent hypoxia (IHT) as B+ (7.2/10) based on strong evidence, med benefit magnitude, and a low-med-risk safety profile.

'Live high, train low' is the most extensively studied altitude strategy for endurance performance.

Studied, labeled, or reported-use context: Live-high train-low (LHTL) 2,200-2,500m for 3-4 weeks; IHT 10-15% FiO2 in 5 min intervals — N/A; not individualized guidance.

What the evidence says

'Live high, train low' is the most extensively studied altitude strategy for endurance performance. Intermittent hypoxia devices (LiveO2, CellGym) becoming popular in biohacker circles with less robust evidence.

Mechanism

Hypoxia stabilizes HIF-1α; EPO production; erythropoiesis; increased mitochondrial density and capillarization; possibly enhanced autophagy

Studied, labeled, or reported dose & route

Live-high train-low (LHTL) 2,200-2,500m for 3-4 weeks; IHT 10-15% FiO2 in 5 min intervals

This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.

Citations

A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.

Common questions

What does the evidence show about Altitude training / intermittent hypoxia (IHT)'s effects?
Read Off Label rates the evidence for Altitude training / intermittent hypoxia (IHT) as Strong and the benefit magnitude as med, producing an overall grade of B+ (7.2/10). 'Live high, train low' is the most extensively studied altitude strategy for endurance performance.
What safety findings are reported for Altitude training / intermittent hypoxia (IHT)?
Altitude training / intermittent hypoxia (IHT) has a low-med risk profile in the database. Low-Med (altitude sickness; contraindicated in severe CV/pulmonary disease) Legal status: N/A.
What doses or routes are reported for Altitude training / intermittent hypoxia (IHT)?
Live-high train-low (LHTL) 2,200-2,500m for 3-4 weeks; IHT 10-15% FiO2 in 5 min intervals This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
How does Altitude training / intermittent hypoxia (IHT) work?
Hypoxia stabilizes HIF-1α; EPO production; erythropoiesis; increased mitochondrial density and capillarization; possibly enhanced autophagy

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.